
Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9UN3IySG5RVVViblpISkY3S3FGenhTTXdGSDBobUlsYld4T1p6T3VOWGdWZ1N3akhDRHR2dGxtclVHa1J5aHY2a2VwZTZmaFRDWEZCWkItXzRYRHJuRUlj?oc=5" target="_blank">Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
